[1] |
LI Ya, LIU Hui, REN Jingjing, LI Xiaofu, ZHI Yanfang.
Early diagnostic value of methylation in promoter region of FAM19A4, PAX1 and miRNA124-2 in cervical lesions
[J]. China Oncology, 2024, 34(8): 734-744.
|
[2] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[3] |
LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan.
Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(7): 669-679.
|
[4] |
CHEN Yuanxiang, YU Tao, YANG Shiyu, ZENG Tao, WEI Lan, ZHANG Yan.
KDM4A promotes the migration and invasion of breast cancer cell line MDA-MB-231 by downregulating BMP9
[J]. China Oncology, 2024, 34(2): 176-184.
|
[5] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
[6] |
CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan.
Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
[J]. China Oncology, 2023, 33(5): 469-477.
|
[7] |
GUO Qing, ZHANG Jian.
Advances in targeted therapy for HER2-low breast cancer
[J]. China Oncology, 2023, 33(2): 181-190.
|
[8] |
ZHANG Xiaowei, LIU Xin, LUO Zhiguo.
Progress in clinical management of cancer of unknown primary based on molecular testing at 2023 ESMO
[J]. China Oncology, 2023, 33(11): 989-992.
|
[9] |
MA Xiao, XIANG Jiaqing, MA Longfei.
Surgical treatment of esophagotracheal fistula caused by neoadjuvant chemotherapy for locally advanced esophageal cancer: a case report
[J]. China Oncology, 2022, 32(6): 542-544.
|
[10] |
DUAN Yuqing, XIA Ning, JIA Yunlong, ZHENG Wenya, LIU Lihua.
SRSF1 promotes proliferation, invasion and migration of esophageal squamous cell carcinoma Eca9706 cells by regulating VEGFA mRNA alternative splicing
[J]. China Oncology, 2022, 32(3): 191-199.
|
[11] |
GONG Chao , CHEN Kui , ZHANG Dekun , XIE Jingfeng , WU Fanghua , HUANG Yudian , XUE Yuqin , WANG Liqun .
Construction of a prediction model for metastasis in gastric cancer based on the weighted gene co-expression network analysis
[J]. China Oncology, 2021, 31(8): 746-753.
|
[12] |
CHEN Jie, WANG Yan, ZHANG Weimin, ZHAO Di, ZHANG Lingyuan, ZHAN Qimin.
Hypoxia induces expression of IL-7 in esophageal squamous cell carcinoma to promote tumor progression
[J]. China Oncology, 2021, 31(5): 361-367.
|
[13] |
LIU Bin , ZHENG Pengyuan , MI Yang , REN Feifei , GAO Shuang , LIU Chuan , LI Fazhan .
Expression of LRP8 in gastric cancer and its significance in tumorigenesis
[J]. China Oncology, 2021, 31(4): 285-293.
|
[14] |
ZHANG Jinzhong , LI Yueqi , SHI Ke , YANG Liang , GUO Dan .
Expression and clinical significance of PLK4 gene in esophageal squamous cell carcinoma and its effect on cell proliferation, invasion and migration
[J]. China Oncology, 2021, 31(12): 1185-1193.
|
[15] |
FENG Bo, WANG Gaoyan, LIANG Xiaoliang, WU Zheng, GUO Yanli, SHEN Supeng, GUO Wei.
The expression level of FAM83H in esophageal squamous cell carcinoma and its effect on biological characteristics of esophageal cancer cells
[J]. China Oncology, 2020, 30(9): 674-681.
|